Clinical genetic strategies for early onset neurodegenerative diseases

다국어 초록 (Multilingual Abstract)

Purpose of review: Methods for the genetic diagnosis of neurodegenerative disorders were reviewed, including their backgrounds and applications in the laboratory.
Majority of disease-causing gene mutations were uncommon in the general population, where dominant variations could be easily identified in certain disorders.
The development of molecular, next generation sequencing (NGS) and cytogenetic techniques allowed to identify multiple genetic mutations leading to diseases.
Using of the accurate multivariate diagnosis of diseases would be essential for appropriate treatment of patients, genetic counseling and prevention strategies Recent findings: Abnormal genes play an extremely important role in the pathogenesis of neurodegenerative disorders of the nervous system. Many studies of genetic have clearly indicated that the molecular mechanisms underlying the etiology and pathogenesis of most neurodegenerative disorders until now. Mutation is necessary for life, while fidelity is necessary for DNA replication. Mistakes in DNA replication/transcription can cause cells to produce either too much or too little protein or a defective protein. Studies on mutations have revealed the normal functions of genes, messages, proteins, the causes of many diseases, and the variability of responses among individuals. Based on the presence of damaging variants, there are many genes have identified that associated with neurodegenerative disorders through to genetic analyses of patients. This declaration is interesting because also our previous analysis has shown that several types of neurodegenerative diseases associated with abnormal genes function have been well described, including Alzheimer’s disease (AD), front temporal dementia (FTD), amyotrophic lateral sclerosis (ALS), prion disease, and Parkinson’s disease (PD). Since the potential treatment strategies for these disorders may be more successful during the pre-clinical stages than in the actual clinical setup, accurate, simple, and affordable diagnostic methods are needed. A mutation can be defined as a sequence change in a test sample compared to the sequence of a reference standard. This has led to the development of methods for screening and detecting abnormal DNA, including techniques that detect previously described mutations(genotyping) and those that scan for mutations in a particular target region (mutation scanning). This review provides a broad overview of the range of currently available mutation detection techniques with special emphasis on neurodegenerative disorders in humans. We have discussed the methods used for detecting unknown mutations, such as ribonuclease, denaturing gradient-gel electrophoresis, carbodiimide, chemical cleavage, single-strand conformation polymorphism, heteroduplex, and sequencing. Furthermore, other diagnostic methods for testing mutations include allele-specific oligonucleotide hybridization; allele-specific amplification, ligation, primer extension, and the artificial introduction of restriction sites are also reviewed. In order to identify the mutation, the last of the work provides basic insights into some of the most popular in silico tools for splicing defect prediction from the viewpoint of end users.

참고문헌 (Reference)

• 1 Bao, L., "nsSNPAnalyzer: Identifying disease-associated nonsynonymous single nucleotide polymorphisms" 33 : 480-482, 2005
• 2 Chrystoja, C. C., "Whole genome sequencing as a diagnostic test: challenges and opportunities" 60 : 724-733, 2014
• 3 Hattersley, A. T., "What makes a good genetic association study?" 366 : 1315-1323, 2005
• 4 Kruglyak, L., "Variation is the spice of life" 27 : 234-236, 2001
• 5 Jonsson, T., "Variant of TREM2 associated with the risk of Alzheimer's disease" 368 : 107-116, 2013
• 6 Sauna, Z. E., "Understanding the contribution of synonymous mutations to human disease" 12 : 683-691, 2011
• 7 Logue, M. W., "Two rare AKAP9 variants are associated with Alzheimer's disease in African Americans" 10 : 609-618, 2014
• 8 Rabbani, B., "The promise of whole-exome sequencing in medical genetics" 59 : 5-15, 2014
• 9 Rabbani, B., "The promise of whole-exome sequencing in medical genetics" 59 : 5-15, 2014
• 10 Barnes, D. E., "The projected effect of risk factor reduction on Alzheimer's disease prevalence" 10 : 819-828, 2011
• 11 Chamary, J. V., "The price of silent mutations" 300 : 46-53, 2009
• 12 Rogaeva, E., "The neuronal sortilinrelated receptor SORL1 is genetically associated with Alzheimer disease" 39 : 168-177, 2007
• 13 Rossor, M. N., "The diagnosis of young-onset dementia" 9 : 793-806, 2010
• 14 Rossor, M. N., "The diagnosis of young-onset dementia" 9 : 793-806, 2010
• 15 Kelley, L. A., "The Phyre2 web portal for protein modeling, prediction and analysis" 10 : 845-858, 2015
• 16 Yang, J., "The I-TASSER Suite: Protein structure and function prediction" 12 : 7-8, 2015
• 17 Thomas, P. D, "The Gene Ontology and the Meaning of Biological Function" 1446 : 15- 24, 2017
• 18 van Dijk, E. L., "Ten years of next-generation sequencing technology" 30 : 418-426, 2014
• 19 Kallberg, M., "Template-based protein structure modeling using the RaptorX web server" 7 : 1511-1522, 2012
• 20 Rosenbaum, V., "Temperature-gradient gel electrophoresis. Thermodynamic analysis of nucleic acids and proteins in purified form and in cellular extract" 26 : 235-246, 1987
• 21 Plotkin, J. B., "Synonymous but not the same: the causes and consequences of codon bias" 12 : 32-42, 2011
• 22 Greenwood, P. M., "Synergistic effects of genetic variation in nicotinic and muscarinic receptors on visual attention but not working memory" 106 : 3633-3638, 2009
• 23 Dogan, R. I., "SplicePort: an interactive splice-site analysis tool" 35 : 285-291, 2007
• 24 Schork, N. J., "Single nucleotide polymorphisms and the future of genetic epidemiology" 58 : 250-264, 2000
• 25 Ho, P. Y., "Simultaneous assessment of the effects of exonic mutations on RNA splicing and protein functions" 373 : 515-520, 2008
• 26 Hall, J. G., "Sensitive detection of DNA polymorphisms by the serial invasive signal amplification reaction" 97 : 8272-8277, 2000
• 27 Sharp, A. J., "Segmental duplications and copy-number variation in the human genome" 77 : 78-88, 2005
• 28 Mathew, C, "Science medicine and the future: Postgenomic technologies: hunting the genes for common disorders" 322 : 1031-1034, 2001
• 29 Biasini, M., "SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information" 42 : 252-258, 2014
• 30 Kim, S., "SNP genotyping: technologies and biomedical applications" 9 : 289-320, 2007
• 31 De Baets, G., "SNP effect 4.0: Online prediction of molecular and structural effects of protein-coding variants" 40 : 935-939, 2012
• 32 Emahazion, T., "SNP association studies in Alzheimer's disease highlight problems for complex disease analysis" 17 : 407-413, 2001
• 33 Bromberg, Y., "SNAP: predict effect of nonsynonymous polymorphisms on function" 35 : 3823-3835, 2007
• 34 Bromberg, Y., "SNAP: predict effect of nonsynonymous polymorphisms on function" 35 : 3823-3835, 2007
• 35 Gatz, M., "Role of genes and environments for explaining Alzheimer disease" 63 : 168-174, 2006
• 36 Giau, V. V., "Role of apolipoprotein E in neurodegenerative diseases" 11 : 1723-1737, 2015
• 37 Sarmiento, U. M., "Restriction fragment length polymorphism of the major histocompatibility complex of the dog" 28 : 117-124, 1988
• 38 Schattner, P., "Regions of extreme synonymous codon selection in mammalian genes" 34 : 1700-1710, 2006
• 39 Ronaghi, M., "Real-time DNA sequencing using detection of pyrophosphate release" 242 : 84-89, 1996
• 40 Cruchaga, C., "Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease" 505 : 550-554, 2014
• 41 Shapiro, M. B., "RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression" 15 : 7155-7174, 1987
• 42 Ronaghi, M, "Pyrosequencing sheds light on DNA sequencing" 11 : 3-11, 2011
• 43 Corder, E. H., "Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease" 7 : 180-184, 1994
• 44 Corder, E. H., "Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease" 7 : 180-184, 1994
• 45 Reva, B., "Predicting the functional impact of protein mutations: Applications to cancer genomics" 39 : e118-, 2011
• 46 Choi, Y., "Predicting the functional effect of amino acid substitutions and indels" 7 : e46688-, 2012
• 47 Kumar, P., "Predicting the effects of coding non-synonymouse variants on protein function using the SIFT algorithm" 4 : 1073-1081, 2009
• 48 Ng, P. C., "Predicting deleterious amino acid substitutions" 11 : 863-874, 2001
• 49 Knopman, D. S., "Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology" 56 : 1143-1153, 2001
• 50 Kim, M., "Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity" 18 : 3987-3996, 2009
• 51 Lyamichev, V., "Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes" 17 : 292-296, 1999
• 52 Lu, J., "Polymorphic Variation in Cytochrome Oxidase Subunit Genes" 21 : 141-154, 2010
• 53 Stone, E. A., "Physicochemical constraint violation by missense substitution mediates impairment of protein function and disease severity" 15 : 978-986, 2005
• 54 Stone, E. A., "Physicochemical constraint violation by missense substitution mediates impairment of protein function and disease severity" 15 : 978-986, 2005
• 55 Mi, H., "PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees" 41 : 377-386, 2013
• 56 Chen, R., "Non-synonymous and synonymous coding SNPs show similar likelihood and effect size of human disease association" 5 : e13574-, 2010
• 57 Sun, Y., "Next-generation diagnostics: gene panel, exome, or whole genome?" 36 : 648-655, 2015
• 58 Luthra, R., "Next-Generation Sequencing in Clinical Molecular Diagnostics of Cancer: Advantages and Challenges" 7 : 2023-2036, 2015
• 59 Perl, D. P, "Neuropathology of Alzheimer's disease" 77 : 32-42, 2010
• 60 Meyer, J. M., "Multiple threshold model for the onset of Alzheimer's disease in the NAS-NRC twin panel" 81 : 92-97, 1998
• 61 Lambert, J. C., "Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease" 45 : 1452-1458, 2013
• 62 Deng, M., "Mapping Gene Ontology to proteins based on protein-protein interaction data" 20 : 895-902, 2004
• 63 Pericak-Vance, M. A., "Linkage studies in familial Alzheimer's disease: evidence for chromosome 19 linkage" 48 : 1034-1050, 1991
• 64 Allen, M., "Late-onset Alzheimer disease risk variants mark brain regulatory loci" 1 : e15-, 2015
• 65 Sebat, J., "Large-Scale Copy Number Polymorphism in the Human Genome" 305 : 525-528, 2004
• 66 Ryan, M., "LS-SNP/PDB: Annotated non-synonymous SNPs mapped to protein data bank structures" 25 : 1431-1432, 2009
• 67 Tavtigian, S. V., "In silico analysis of missense substitutions using sequence-alignment based methods" 29 : 1327-1336, 2008
• 68 Reese, M. G., "Improved splice site detection in Genie" 4 : 311-323, 1997
• 69 Ronaghi, M, "Improved performance of pyrosequencing using single-stranded DNA-binding protein" 286 : 282-288, 2000
• 70 Capriotti, E., "I-Mutant2.0: Predicting stability changes upon mutation from the protein sequence or structure" 33 : 306-310, 2005
• 71 Nackley, A. G., "Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure" 314 : 1930-1933, 2006
• 72 Desmet, F. O., "Human Splicing Finder: an online bioinformatics tool to predict splicing signals" 37 : e67-, 2009
• 73 McGall, G. H., "High-density GeneChip oligonucleotide probe arrays" 77 : 21-42, 2002
• 74 Bergem, A. L, "Heredity in dementia of the Alzheimer type" 46 : 144-149, 1994
• 75 Stephens, J. C., "Haplotype variation and linkage disequilibrium in 313 human genes" 293 : 489-493, 2001
• 76 Yang, S. Y., "HSD17B10: A gene involved in cognitive function through metabolism of isoleucine and neuroactive steroids" 92 : 36-42, 2007
• 77 Wade, C. H., "Growing up in the genomic era: implications of whole-genome sequencing for children, families, and pediatric practice" 14 : 535-555, 2013
• 78 Redon, R., "Global variation in copy number in the human genome" 444 : 444-454, 2006
• 79 Harold, D., "Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease" 41 : 1088-1093, 2009
• 80 Lambert, J. C., "Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease" 41 : 1094-1099, 2009
• 81 Seshadri, S., "Genome-wide analysis of genetic loci associated with Alzheimer disease" 303 : 1832-1840, 2010
• 82 Margulies, M., "Genome sequencing in microfabricated high-density picolitre reactors" 437 : 376-480, 2005
• 83 Kowalska, A., "Genetic study of familial cases of Alzheimer's disease" 51 : 245-252, 2004
• 84 Bird. D. T, "Genetic Aspects of Alzheimer Disease" 10 : 231-239, 2008
• 85 Bird, D. T, "Genetic Aspects of Alzheimer Disease" 10 : 231-239, 2008
• 86 Pertea, M., "GeneSplicer: a new computational method for splice site prediction" 29 : 1185-1190, 2001
• 87 Vo Van Giau, "Gene panels and primers for next generation sequencing studies on neurodegenerative disorders" 대한독성 유전단백체 학회 11 (11): 89-143, 2015
• 88 Lee, J. S., "GObar: a gene ontology based analysis and visualization tool for gene sets" 6 : 189-, 2005
• 89 Calabrese, R., "Functional annotations improve the predictive score of human disease-related mutations in proteins" 30 : 1237-1244, 2009
• 90 Tuzun, E., "Fine-scale structural variation of the human genome" 37 : 727-732, 2005
• 91 Al-Shahrour, F., "Fati-GO: a web tool for finding significant associations of Gene Ontology terms with groups of genes" 20 : 578-580, 2004
• 92 Rogaev, E. I., "Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene" 376 : 775-778, 1995
• 93 Tosto, G., "F-box/LRR-repeat protein 7 is genetically associated with Alzheimer's disease" 2 : 810-820, 2015
• 94 Grupe, A., "Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants" 16 : 865-873, 2007
• 95 So, H. C., "Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases" 35 : 310-317, 2011
• 96 Nyren, P, "Enzymatic method for continuous monitoring of DNA polymerase activity" 167 : 235-248, 1987
• 97 Farrer, L. A., "Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease" 278 : 1349-1356, 1997
• 98 Oberacher, H., "Direct molecular haplotyping of multiple polymorphisms within exon 4 of the human catechol-Omethyltransferase gene by liquid chromatography-electrospray ionization time-of-flight mass spectrometry" 386 : 83-91, 2006
• 99 Orita, M., "Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms" 86 : 2766-2770, 1989
• 100 Iafrate, A. J., "Detection of large-scale variation in the human genome" 36 : 949- 951, 2004
• 101 Zhou, Q., "Detection of RASA1 mutations in patients with sporadic Sturge-Weber syndrome" 27 : 603-607, 2011
• 102 Wartell, R. M., "Detecting base pair substitutions in DNA fragments by temperature-gradient gel electrophoresis" 18 : 2699-2705, 1990
• 103 Sanger, F., "DNA sequencing with chain-terminating inhibitors" 74 : 5463-5467, 1977
• 104 Mathew, C. G, "DNA diagnostics: goals and Challenges" 55 : 325-339, 1999
• 105 Botstein, D., "Construction of a genetic linkage map in man using restriction fragment length polymorphisms" 32 : 314-331, 1980
• 106 Belmont, J. W., "Complex phenotypes and complex genetics: an introduction to genetic studies of complex traits" 27 : 180-187, 2005
• 107 Carmel, I., "Comparative analysis detects dependencies among the 5' splice-site positions" 10 : 828-840, 2004
• 108 Webb, B., "Comparative Protein Structure Modeling Using Modeller" 47 : 5.6.1-5.6.32, 2014
• 109 Naj, A. C., "Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with lateonset Alzheimer's disease" 43 : 436-441, 2011
• 110 Hollingworth, P., "Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease" 43 : 429-435, 2011
• 111 Tzvetkov, M. V., "Common genetic variations in human brain-specific tryptophan hydroxylase-2 and response to antidepressant treatment" 18 : 495-506, 2008
• 112 Bindea, G., "ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks" 25 : 1091-1093, 2009
• 113 Sherrington, R., "Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease" 375 : 754-760, 1995
• 114 Levy-Lahad, E., "Candidate gene for the chromosome 1 familial Alzheimer's disease locus" 269 : 973-977, 1995
• 115 Ribases, M., "Association study of 10 genes encoding neurotrophic factors and their receptors in adult and child attention-deficit/hyperactivity disorder" 63 : 935-945, 2008
• 116 Cardon, L. R., "Association study designs for complex diseases" 2 : 91-99, 2001
• 117 Cardon, L. R., "Association study designs for complex diseases" 2 : 91-99, 2001
• 118 Tanzi, R. E., "Assessment of amyloid ${\beta}$-protein precursor gene mutations in a large set of familial and sporadic Alzheimer disease cases" 51 : 273-282, 1992
• 119 Dean, M, "Approaches to identify genes for complex human diseases: Lessons from Mendelian disorders" 22 : 261-274, 2003
• 120 Leong, I. U., "Application of massively parallel sequencing in the clinical diagnostic testing of inherited cardiac conditions" 2 : 98-126, 2014
• 121 Strittmatter, W. J., "Apolipoprotein E: highavidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease" 90 : 1977-1981, 1993
• 122 Locke, P. A., "Apolipoprotein E4 allele and Alzheimer disease: examination of allelic association and effect on age at onset in both early- and late-onset cases" 12 : 83-92, 1995
• 123 Namba, Y., "Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and cru plaque amyloid in Creutzfeldt-Jakob disease" 541 : 163-166, 1991
• 124 Selkoe, D. J, "Alzheimer's disease: genes, proteins, and therapy" 81 : 741-766, 2001
• 125 Hebert, L. E., "Alzheimer disease in the US population: prevalence estimates using the 2000 census" 60 : 1119-1122, 2003
• 126 Ng, P. C., "Accounting for human polymorphisms predicted to affect protein function" 12 : 436-446, 2002
• 127 Watanabe, Y., "A two-stage case-control association study of PADI2 with schizophrenia" 54 : 430-432, 2009
• 128 Adzhubei, I. A., "A method and server for predicting damaging missense mutations" 7 : 248-249, 2010
• 129 Landegren, U., "A ligase-mediated gene detection technique" 241 : 1077-1080, 1988
• 130 Coon, K. D., "A highdensity whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease" 68 : 613-618, 2007
• 131 Dhaenens, C. M., "A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease" 35 : 474-476, 2009
• 132 Kimchi-Sarfaty, C., "A 'silent' polymorphism in the MDR1 gene changes substrate specificity" 315 : 525-528, 2007